How Delta Pilots Build Liquidity, Planning Around the 2028 Estate Exemption, the Anthropic IPO, and Selling Your Practice to Private Equity

Transcript

Intro

Stephan Shipe: Welcome back to the Scholar Wealth Podcast. This week we begin with an airline captain whose retirement savings sit inside three airline-owned plans, an 18% company match to a 401(k), a cash balance plan for the overflow, and a frozen defined benefit pension from an old merger. He has little optionality and wants to know where to put the money that he could still reach. Then we hear from a couple with a closely held business. They moved a big piece of their estate exemption into a SLAT in 2024 out of fear of the sunset, and with more elections on the horizon, they want to know how to plan. Next, a quick one from a listener who just got the Fidelity letter asking if he wants in on the Anthropic IPO. He wants to know what to put on his indication of interest. And in our From the Field segment this week, we’re joined by Thomas Allen, who has led nearly 200 practice sales to private equity across dental, dermatology, and veterinary. We cover what a headline multiple gets you, earnouts, and the real estate play. So let’s get started with question one today.


Question 1 – Great Airline Retirement Benefits, No Liquidity: Where Should the Reachable Money Go?

Stephan Shipe: I’m fifty-one, a captain at Delta Airlines, fourteen years from mandatory retirement. The company puts eighteen percent of my pay into my 401(k). I max my own deferrals on top, and the overflow goes into a market-based cash balance plan the airline runs. There’s also a frozen defined benefit plan from the Northwest merger. On paper, my net worth looks great, but in practice we’re still completely illiquid and have little optionality. Any tips for what I should be doing with the money I can reach right now?

So this is really neat, because a lot of people don’t realize how awesome the retirement benefits are for airlines. You see this not only at Delta, but American Airlines has this, United Airlines, all the airlines are really stacked with great options for a 401(k). They’re some of the highest 401(k) contributions that you can get, where in your case, eighteen percent, I’ve seen twenty percent, seventeen percent, all in these numbers, which is wild, especially because compensation as an airline pilot is not too shabby as well. So it’s possibly hundreds of thousands of dollars going into retirement plans every single year. The only bad part about that is that it’s all locked up. So you can’t touch it until retirement.

But fun fact, for those who are unaware of why the 401(k) is so large at a lot of these airlines, it has a lot to do with the transition. We saw this with auto companies as well, of large corporations moving from pension plans to 401(k)s. So basically you had a defined benefit plan, which said the company is now responsible for the benefits of your retirement. So basically supplementing Social Security, this was really big in kind of the baby boom era, where you had the big three car manufacturers and they had these massive pensions where you could go work somewhere, retire, and they would basically continue your pay throughout retirement. That ended, very big in the 80s, 90s, especially the 90s really started to take this over, and companies started to say, I want to remove that risk from our balance sheet. I don’t want to be responsible for somebody’s retirement. How about they’re responsible for their retirement, but we’ll just add cash in like we would have for the pension. But now we’re not worried about pension underfunding or any issues that come with that. So that’s where the 401(k) and a lot of these defined contribution plans came from.

Airlines are no different. You run into a lot of frozen defined benefit plans or old pensions that have been bought out, where they’ve shifted from, we’re not going to do a pension anymore. Not all the airlines are doing this, some of them still have pensions as you’re seeing, but you have this pension shift where it’s, we’re not doing pensions, but we’re going to contribute a ton to a 401(k). And that also has to do with bargaining as well. Airlines are heavily unionized from a pilot perspective. And it’s very hard to run an airline if no one’s flying the plane. So a ton of negotiating power there. So good on you for having that. And you also have the mandatory retirement, which you had mentioned. So you have to retire as a pilot at age 65. So we have a lot of issues at play.

The big issue that comes up is exactly what you nailed. You have all of these retirement benefits. They’re great. You have these pensions, you have the 401(k). Everything is stacking up in your net worth. So net worth looks fantastic, but you can’t actually spend it because you can’t touch it. So the bad part of this is we need your net worth to be even higher, and you need it to be even higher in the right spot. So right now you’ve got a huge tax-deferred, maybe a Roth bucket if you have that there, but you have no liquid assets. You don’t have a taxable brokerage account that’s large enough to be able to give you the flexibility that you desire right now and that you’re probably going to want. In other words, you go retire and you want to go buy a vacation home or something like that. You can’t do that with a 401(k) without taking a ridiculous amount in tax.

So when you’re at this stage, where we’ve got fourteen years from retirement, that puts you at, you know, in your early fifties. You have plenty of time to start stacking up some of your savings in a brokerage account. And these are the heyday years. I mean, usually your normal trajectory for the American dream, so to speak, is that early on a career, income’s not that great, but you also have all your high expenses, your down payments on homes, kids, college, all of those things. And then you hit exactly where you’re at now. Your 50s, most of your big expenses are paid for. You’re earning the top amount that you can. You have the max amount of flexibility in your job. So cash is just rolling in.

I would focus on that cash rolling in going into a brokerage account. I’d be a little hesitant, or at least I would be watching, how much I’m adding more so to these tax-deferred or Roth accounts. As much as that’s not a perfect tax answer, we’ve seen this happen a lot where I’ll talk to somebody who is in your shoes, like, I’m making great money, I have these options to go put all this money away, but they end up burning all of their savings into deferred accounts and they don’t have any in the brokerage. So they don’t have as much flexibility as they want. I would really encourage you to start looking at what you need for retirement, see if that’s already covered by your 401(k) and future contributions to that 401(k) by the company, and then start to prioritize liquidity for the next 10 years or so, to give you a lot of optionality early in retirement and possibly even earlier retirement, if that’s what you’re looking for.


Question 2 – Another Round of Irrevocable Gifting Based on Election Polls?

Stephan Shipe: My husband and I are in our late 60s and our net worth is around 22 million, mostly in a closely held manufacturing business we spent 30 years building. We burned through a big piece of our estate exemption on a SLAT in 2024 because we were terrified of the sunset. And now our attorney says the exemption is permanent at 15 million, but could drop to 3.5 million if Democrats win in 2028. I feel sick thinking about doing another round of irrevocable gifting based on election polls. We’re exhausted, we don’t want to give away too much and regret it. And we’re equally scared we’ll sit still and get crushed. How are we supposed to plan right now?

So we can make this really easy and say that when you’re dealing with the estate exemptions, that seems like a next-generation problem, right? You first have to worry about being able to get through retirement and get through your life without running out of money. That’s goal number one. So regardless of what taxes are, estate tax could be 80%, and I would still tell you that the first thing we need to do is to look at how much money do you actually need to do all the things you’re wanting to do, before we start giving it away. Because you are absolutely right that the problem with doing any of these irrevocable contributions is you can’t revoke it, by definition. So it’s gone. You’re moving this money out of your estate. This is the same reason that I get a little hesitant when somebody says, well, I’m going to give to charity to save on taxes. It’s like, well, of course you’re going to be able to save on tax if you give to charity, because you’re giving the money away. It’s no longer yours. So you’re giving away the dollar to save 30 cents. And you’re dealing with the same thing with the estate.

So I do think that before getting into any other details related to this, we have to be careful not to jump too far into these decisions based on potential tax changes. And that goes back into, I’m a big fan of not letting the tax tail wag the dog. And that is exactly what this starts to sound like whenever you have estate concerns. And could it drop from 15 to 3.5? Absolutely. Of course it could drop, but we don’t know that. And you know what? Even if it did drop, it’s not likely to drop, the bill comes out on a Monday and on Tuesday the estate limit drops. It’s going to take some time. And with that time, we can do the same thing you did a few years ago, of evaluate it and say, is there any room for you to take more out of your estate and put it somewhere else? And you can move that out and take advantage of any higher estate exemption that may exist at that point. So I think that’s the first thing out of the way.

The next is that this is still two years away. Trump still has veto power on this. So the odds of there being a lot of wide ranges of tax law changes, especially around the estate, is very unlikely. Now, 2028, maybe, right? But that’s 2028 for a 2029 decision that likely drops in 2030 or 2031. So we have some time out here to think about this and really evaluate what your portfolio is doing, what your spending’s doing. I mean, who knows? The stock market could double in that time. It could also drop in half. So we don’t know where we’re going to be five years from now to start making decisions, or for you to worry about it. We don’t need you here with a successful business that you’ve been running for 30 years, worried about what’s going to happen to the estate limit out in the future.

And I’m not saying that that doesn’t mean you should plan ahead. I’m saying you have sufficient time to plan ahead. And you’ve probably got two years before you really need to start looking at this in a deeper way. And a lot can change in two years. But you are not alone in being worried about that. There’s a lot of different things that are being tossed around now, with top marginal rates increasing, with the estate limit, especially as business owners, like you, especially in manufacturing. I mean, you have a lot of things that could hit here, with changes to depreciation and accelerated depreciation, that bonus depreciation stuff that’s come out the past few years that have been very beneficial to businesses could go away or could change. So it’s not just the estate limit. There’s a lot of stuff that we need to evaluate. And do I think taxes go up? Probably. I mean, we’re at historically low tax rates and historically high national debt. So you combine those two together, and probably tax rates going up and probably exemptions going down. But we don’t know that yet.

And I don’t want you making any fast decisions on something that can’t be reversed. And you want to make sure that you keep as much optionality as possible. And right now, I’d say not doing any of that gives you some more optionality. And of course, we’ve got to evaluate that in a lot of different ways and deal with the attorneys and have them give opinions on this as well. But for right now, start with what you need, keep the optionality on it, and try to go the next couple of years without worrying about it too much, until we start getting something more concrete than just someone’s idea of a bill that may happen sometime in the future. But you’re not alone. It’s a common question coming up, especially the past week. We actually released a letter this week to all of our clients. If you want it, we can put a link to it in the show notes, or you can sign up for the newsletter and you get it yourself. So you can go through what some of those proposals are and how likely we believe that they are to exist.


Question 3 – What Should You Put on an Indication of Interest for the Anthropic IPO?

Stephan Shipe: I just got a letter from Fidelity asking if I want in on the Anthropic IPO. Should I put the full amount I want on my indication of interest?

So the indication of interest, this actually just came up not too long ago on episode sixty-five. We covered the full IPO playbook. So we can create a link to that as well, so you can view that. The IOIs are not guaranteed. I think that’s probably one of the biggest misconceptions. Somebody comes and says, my broker allowed me to have access to the Anthropic IPO, so I’m going to tell them I want to own a hundred shares. And then you throw your hundred shares in there, you actually get, you know, two shares or something like that. And even that would be generous on a hundred shares. I mean, we’ve seen indications of interest of thousands of shares only get 40 or 50 shares. So it’s good that you got an offer to do that. I would be careful on how you hedge that, because without getting in too much detail on it, you don’t want to have a huge indication of interest and then get that filled and now you own a ridiculous amount of Anthropic. But you likely are going to have to put an indication of interest that’s larger than what you’re actually going to get, knowing that the allocation you get is going to be well below what you’re asking for.


From the Field – Selling a Practice to Private Equity: Headline Multiples, Earnouts, and the Real Estate Play

In our From the Field segment, we’re joined by Thomas Allen, founder and CEO of Practice Transitions Group in Austin, Texas. Thomas and his team have represented physicians on nearly 200 practice sales over the last 12 years, primarily into private equity. We talked through the difference between headline multiple and what actually hits the bank, why earnouts rarely pay out, which is always a mess, and how practice real estate can unlock extra value at exit, and the three things to start doing three years before you actually have a sale.

Stephan Shipe: All right, Thomas, welcome to the Scholar Wealth Podcast. To start off today, why don’t you give us a little bit about your background, how you got into this?

Thomas Allen: Yeah, so Thomas Allen, president and founder and CEO of Practice Transitions Group. We’re based here in Austin, Texas. So we got into this through an interesting path. Me and my co-founder started a company called Practice Real Estate Group, where we were helping all types of doctors, dentists, veterinarians find great locations to open their practices. And through that, started seeing private equity enter the world, and we were helping a lot of private-equity-backed entities open multiple locations all across the country. And we had some early clients that were not private-equity-backed, but they had gotten to two, three, four locations and they were looking to sell their practices into private equity. And there was a real dearth of good advisors, and we had built a lot of trust with them over the years. And then we had actually invested in some practices where we had hired an outside party, not a broker, investment banker, to help us sell them, and watched that process. And so when these particular clients came to us, they asked us to represent them because of that trust we’d built. And that would have been in 2014. And that’s how we got the first few transactions under our belt as advisors. Fast forward almost 12 years now, and we’re approaching two hundred transactions where we’ve been the lead advisor on and selling practices to private-equity-backed entities primarily.

Stephan Shipe: So is it mostly to just private equity? Are you doing any type of advising on like internal sales as well, like that succession planning?

Thomas Allen: So we do have some clients where they’re selling to maybe internal associates, and how do we phase that over time and what’s the best structure in that. And then we do have a division where we handle sales to other providers, other doctors, on certain practices where doctors are interested in that plan as opposed to joining up with a larger group.

The Waves: Dermatology, Dental, and What’s Coming Back

Stephan Shipe: Have you seen that market change? I know when we’re talking over the past, say over the past five years or so, it seems like everyone’s either concerned about PE buying their practice or excited about PE buying their practice. And that goes for all different types of healthcare practices. But I know there seemed to be a spike a few years ago around dermatology, and that really kicked off. And I haven’t seen too much of that now. It might be just anecdotal, but then dental practices have had this kind of constant PE pressure over the past few years. What do you see when you’re looking at these different types of waves in the market?

Thomas Allen: So almost every doctor comes to us with questions of, what’s the difference between selling my practice to other doctors versus private equity? And even if they have friends that have sold to private equity and they’ve heard great experience, or friends that have sold to private equity and they’ve had poor experiences, they come to us wondering what’s the right path for them, right? And our job as an advisor is to look at the practice and then present them their options and let them choose from there. And the reality is there are many practices at this point that have built to such a size where the reality of selling to another doctor or two or three or four is going to be very hard to finance. The doctors aren’t necessarily, you know, we’re entering a wave where school’s only gotten more expensive. So a lot of these younger doctors have so much debt that they are concerned with taking out more, especially for a larger practice. And the best option for a lot of these doctors is to sell to one of these private-equity-backed roll-ups or groups.

And in terms of the waves, you are correct. So let’s start with dermatology. We saw that wave happen from, call it 2014 to maybe 2020, 2021, and then it kind of died out, and we’re seeing a resurgence in that. We are working with more dermatologists than we ever have right now. And we are seeing great structures, not just multiples and headline value, but great structures for them as sellers and them as partners entering these larger groups. And then in dental, we’re seeing a little bit of a bounce back as well. So dental started kind of happening in 2014, 2015, 2016. It was kind of the slow build, and then 2017 through 2021 was crazy. We still talk about December of 21. I don’t even know how many hours we put in, because we had so many transactions closing that December. And then we’ve seen a little bit of a pullback and a slowdown in that market, but we’re seeing another resurgence, where we’ve got a few practices on the market right now where some of the offers coming in, in terms of headline value and the way they’re structured, remind me of the days of 21, which is interesting with all the macro environment you hear. But bottom line is, the doctors kind of don’t know what to think or what’s the best course of action for their practice, because they don’t know how to analyze it and understand what options they’re going to have out there.

Headline Multiple vs. What Hits the Bank

Stephan Shipe: Yeah, can you talk a little, I know you’re talking about headline value, and maybe for those who are unfamiliar, the difference there between headline value, multiples, and how the structures are typically set up, maybe with a couple of examples, because that seems to be one of the biggest misconceptions. Somebody comes in and says, well, my practice is valued at seven million dollars or five million dollars, and then they don’t realize that, like, well, six million’s in an earnout or one million’s in rollover equity, and you’re really only getting a couple hundred grand in cash. Obviously that’s an extreme scenario, but can you walk through that a little bit about what you typically see, or some examples?

Thomas Allen: Right, no, absolutely. So we hear all the time, doctor comes in, well, my friend got a nine-times EBITDA multiple. And why are you telling me that you think it’s only worth seven and a half times? And my response is, well, let’s start with multiple. So multiple means multiple on EBITDA, and that’s what I’m calling a headline value. So let’s, for easy math, let’s say your EBITDA, which is earnings before interest, taxes, depreciation, and amortization, which is really a fancy acronym for net operating income after paying all employees and you as a provider, post-transaction, a market compensation rate, which we can go into how those are structured. So it’s a million dollars of EBITDA, seven times, seven million dollars. Well, let’s just say his friend said, well, I had a million of EBITDA and I got nine times, nine million dollars. Well, if your friend had a million of EBITDA and got nine times, they probably got a great deal, but most likely they’re not telling you the truth. That’s number one. Number two is, maybe they did get a nine-times EBITDA multiple, but that would probably be something structured as lower cash at close. Maybe it was fifty-one percent cash at close, and the remainder might not even be in equity. Maybe it was an earnout, and maybe it was over five, six, seven, eight years, to where the buyer, for lack of better words, is tricking them to think they got a nine-times EBITDA multiple. But in reality it’s based on this earnout where you have to perform. And then when you do that over time, I mean, they were probably getting a sub-six multiple, right? And the performance is going to be based on the EBITDA moving forward. So that would be an earnout scenario.

What we’re seeing more common in the market is a structure where you’re getting some percentage of cash. When the big pullback happened, we’ll talk about dental where we saw a big pullback. Through 2021, we might get seven to nine times EBITDA or something, and it was probably 75 or 80% in cash, and the remainder was rolled equity into the larger organization, or it was 75 to 80% in cash with part of that the seller was retaining as joint-venture equity, where they were actually maintaining some ownership within their practice, and then part of it was being rolled into the larger organization. The first thing we saw in the pullback was not lower multiples. It was less cash at close. So it kind of got pulled back to maybe 60% cash or less depending on the multiple. And the remainder, a lot of the groups were really trying to force the doctors to roll into the holding company, the larger group. Now, one of the biggest issues with only receiving holding company equity is you typically lose all cash distributions from your practice aside from your pay. So your income goes down quite significantly when that happens. And so you might be getting a 7x multiple, but if you’re getting sixty percent in cash, you know, that’s roughly four times EBITDA in cash. I’m not saying that’s a terrible deal. That’s going to be more than you’re going to get if you sell to another doctor or another group of doctors, but it’s something to watch out for.

Earnouts: Treat Them as Fun Money

Stephan Shipe: And how do you advise on the earnouts? Because I think this is where a lot of the contention comes in, as you were saying, right? People feel like they got tricked. And in a lot of cases they do. And I look at that as, hopefully not, I mean, most of the time I’ve never seen it as a broad, like, malicious intent. People go in and they’re selling their practice, right? They’re going out saying, like, we’re doing great, we’re going to grow this, this, and this. And then the PE firm’s glad to put a contract together that says, well, sure, if you’re going to grow at that level, we’d love to pay you nine times or ten times if that’s going to be the case. And then they sign over, a huge percentage of that payout is an earnout now, and they never really hit those numbers and then they don’t get all of it. And then they come back to your point of saying, well, now I had a poor experience. How do you advise your clients on balancing being optimistic about your practice and selling a very positive thing, while also not being too optimistic that you’re setting yourself up for an earnout that’s never going to be reachable?

Thomas Allen: So the first way that we protect against that is really understanding the why. The why the doctor is looking into a transaction at all, right? Is it because they feel like they built the practice up to a level where they want to keep growing and they want to keep going, but they just can’t, they don’t know the next step to get there, and they’re tired of personally guaranteeing notes and dealing with more employees and recruiting new physicians and having to be out two, three, four hundred, five hundred thousand dollars of salary that they’re committing to that physician before the practice even grows. If that’s a why, we’re going to look at an earnout one way. If it’s more of a wealth management conversation, which I feel like this market, we have shifted to more of those conversations, where this is a wealth management succession planning conversation and why for doing this, we’re going to look at the earnouts in another way, where to a certain extent you shouldn’t count on them at all, right?

But let’s just say there’s going to be a true earnout based on performance of the practice. And I’m not talking about rolled equity into a larger group. I’m not talking about retained equity in your practice. I’m talking about a true earnout of, EBITDA was a million dollars. And we had this happen recently, 48-year-old dentist. He had built a really large practice, and he was a hundred percent owner, and it was a super high margin practice, and we can go into margins later if you’d like, but it was running at almost a 40% EBITDA margin, whereas, to compare, a good dental practice runs at 20% EBITDA margin. Now he had done that because his rent was low. There were reasons for that margin, but at the end of the day, buyers were, and you know, we’re shopping the market, we’re not just talking to one buyer, we’re talking to seven or eight. The buyers were concerned, like, and they’re always going to be concerned about this, how are we going to buy this practice, how can we maintain this 40% margin? And is it even really a 40% margin? And so they were saying EBITDA was a million three, we were saying EBITDA was a million four fifty, and it was. We defended it through quality of earnings, which is a process where they’re verifying that these earnings are true. But they’re saying, well, the day after we buy it, there’s going to be all these new expenses. We’re going to have to give some employees raises. There’s going to be some things that we don’t think we can maintain. And so what we structured in that particular earnout was, we were going to look at EBITDA at the end of every quarter. And we had a whole formula of how EBITDA was going to be calculated. And he was going to get every dollar above that million three fifty for, I believe it was four years. So that was an earnout because margin was high, and we got very specific on the formula.

Now there’s also growth earnouts. So, hey, we’ll pay you half of every piece of growth over closing EBITDA for the next five years. The way to protect against that is to make sure that you understand EBITDA and that it’s very clear in the contract how EBITDA is calculated. I personally, depending on the size and type of the practice, and it’s not possible for everyone, would rather tie these earnouts to revenue as opposed to EBITDA, because EBITDA can be massaged and changed and debated. Revenue, you know, is what hits the bank account.

Stephan Shipe: Yeah, well, it’s also easier to manipulate too, right? Especially when you lose control. If you’re an owner and you go sell and then now somebody else is running the show, they go give everyone a bunch of raises, like you’re saying, or go change around structures or costs and say we’re going to put a bunch into new developments. Well, now your EBITDA’s trashed, because now there’s a growth focus and you don’t hit your earnouts, right? I mean, that’s the story that people are concerned about, exactly what you’re describing.

Thomas Allen: Yeah, and the other thing is, I try to make sure if there’s an earnout in a deal, it is a bonus and it is not part of, like, I’m not, if somebody’s, if I could sit there and say my client got nine times, if I counted these theoretical earnouts over five years, I don’t count that in the multiple or count that in the original deal. You’ve got to count that as fun money.

Rollover Equity and the Liquidity Question

Stephan Shipe: I’m glad you say that, because that’s one thing, we’ve actually covered it on the podcast, the question that’s come up in the past around like earnout payouts. And the number is ridiculously small of earnouts that actually happen, right? If it’s not cash coming into that deal or some other actual true tangible benefit that’s there, the earnout typically is not that much. Do you think the same about kind of rollover equity, or is that more of a liquidity issue of not being able to get out anytime soon or potentially ever?

Thomas Allen: So that’s the big discussion we’re having with potential clients. We’re having with buyers as well. Is, you know, up until the last three or four years, there was great history of these groups recapitalizing, actually returning money to the doctors. And we’ve just entered this period, and that’s the question we’re all asking ourselves, is this a liquidity issue in the larger markets, or is this a fundamental issue in these physician practice roll-up deals? I personally believe it is more macro driven than an issue in these physician roll-up deals, but then still nobody can tell you when the macro stuff’s going to lift and these larger platforms are going to start trading. So what I’m telling buyers as they’re trying to push for more equity is, well, guys, y’all can’t point to any recent liquidity event. And if you want this practice, you’re going to have to either do more cash at closing, or we are finally seeing, which is something I do believe in, especially for younger doctors that may be entering into these partnerships for other reasons, is, hey, what if we kept some of the equity in the practice so we keep this cash flow going, right? So maybe it’s a 70% cash at a nice multiple for a really good practice, with fifteen or twenty percent of retained ownership in the practice, and then the remainder, which would be another 10 or 15%, rolled over into the holding company. And that way the doctor, even if they decide to retire, even if this is a wealth management discussion, if they believe in their practice and they built a good practice, I believe they should, can just keep that cash flow going. And it’s maybe not a terrible retirement asset. And it keeps them kind of hanging around the office, which a lot of them love, they love their businesses. And then they can sell that, if there is recapitalization available to the whole group, they can normally sell all or a portion of that in that recap, or they can sell it to another doctor just at a lower multiple. And we’re starting to model some of that into our exit planning documents that we’re going through with our clients.

Stephan Shipe: How common is that? Are you seeing a lot of people hang out in the practice after they sell? And if so, for how long? Is it kind of throughout that two-to-three-year earnout period? Or is it longer? Longer seems like a hard pill to justify. I mean, that one, I don’t know of many people who once they sold said, I love working for somebody else after they’ve started their business.

Thomas Allen: That’s a fair point. So it obviously depends on the size of practice and the type of practice and what the market’s going to allow to get. You know, we’re seeing commitments as contractual from two to five years, depending on how much single provider risk or whatever. And then a lot of these docs, they do love their practice and their business. And just because they retain, let’s just say they retain fifteen percent of the practice and they retire in three years, that doesn’t mean they have to keep working. They can still own that percentage. And maybe they do like coming to the office a day a week and saying hi to some of their old patients, some of their old staff, and others don’t want to, right? But there can be an exit in that fifteen percent, of selling it to maybe the younger providers that took their place, or continuing to hold on to it.

The Real Estate Arbitrage

Stephan Shipe: How do you handle the real estate ownership component? Because that’s a perfect question for you, given your background of that transition that you had there, but a lot of these practices are owned, the actual building is owned by the owner as well. I can’t imagine that PE’s interested in picking up the real estate as well, but maybe I could be wrong. What do you see there?

Thomas Allen: The vast majority of them are not interested. There are some that have like a real estate sidecar piece where they are interested, but not many. And that real estate sidecar piece can be interesting for the physician selling, because they let the physicians invest in that sidecar piece as well. But the majority are not. And so what we do, we understand the real estate side very well, but we do not then go sell the real estate separately. But the good news for the physician is, if they’re partnering with the right group, they then get to lease the real estate back to that group. And so we focus a lot on structuring the entire deal to take into consideration what that real estate’s worth, right? And so we go negotiate, because once the sale happens and they’ve leased it back to that group, if they want to sell the real estate, the value of that real estate is determined based on the cash flow of the rent that that practice or now that group is paying them and what cap rate that sells for. So we are working with investment sales brokers to make sure we get the rent set up correctly, so that then post-transaction they can go hire the investment sales brokers to go sell that in the capital markets. And there are small, you know, non-tradable, small REITs and other funds that are set up to buy private-equity-backed physician roll-up leased real estate. It’s kind of become an interesting little subset.

Stephan Shipe: Yeah, I like that. That’s a neat additional kind of addendum to that contract, right? If you go in and can lock down the property you own for a really long lease at a highly competitive rate, then it’s not a huge drop to the PE firm to be able to sign that. But for the owner, their ability to go sell that piece of property now with a long-term lease at a really good rate works out really well.

Thomas Allen: Yeah. And we’ll take it a step further. Like if they’ve got a good margin on their practice, we’ll go, hey, we’re probably going to get you seven, eight, nine, ten times for your practice. But if you think of a, you know, a seven percent cap rate, we’ll even go high, a seven percent cap rate, I mean that is what, fifteen, almost sixteen times NOI, right? So like if we can go add another whatever, $30,000 a year to that rate, there’s some real arbitrage there. And so we’re looking at that. Now you can’t go do that if, you know, maybe the practice margin’s a hair on the low side. You don’t want to go weigh it further down because buyers aren’t going to be as interested. But if we look at a practice and the normal margin for this practice is 20% and it’s running at 25, and let’s say it’s a five million dollar top line practice, it’s like, well, let’s go take three percent of that revenue, which is a hundred and fifty thousand a year, put that into the real estate, lower the margin on the practice to twenty-two. Well, that hundred and fifty thousand, I mean, we just unlocked a couple of million dollars in value for that doctor by shifting over to the real estate.

How Much Information to Hand Over, and When

Stephan Shipe: Yeah, I like that idea a lot. That’s a neat way to think about it. Talk to me a little bit about the deal buildup, right? Or the deal timeline. Because one of the questions that I’ll get regularly is, I’ll be talking to a client, they’re thinking about selling their practice, and they talk to a PE firm that has reached out to them, and they inevitably get this long list of documents that are required, right? It’s, we’re going to sign an NDA, but here’s your homework for the next month. I need everything. You’ve got the org chart, I mean, you’ve seen the lists. It’s everything from, you know, every dollar that’s been made for five years, contracts, receivables, all that. The question I always get is, do I need to submit all of that information right now? Or can I phase this in over time? And this is all pre-LOI, right? I mean, this is just for them to take a look at what’s going on. What do you typically advise for how much information, and what’s that next stage where you keep building out more and more information until actual purchase?

Thomas Allen: That’s a great question. So if they’re calling you direct and they want to get all that information before even making, let’s call it, before a term that many doctors might not ever even hear of, an IOI, an indication of interest, I would pause. We have a process that, on most practices, kind of no matter how large they are, we can take a profit and loss statement, a payroll report, and a production by provider, meaning any provider that’s producing income in the practice, like for dermatology, it can be the dermatologists, the PAs, the NPs, the estheticians, the nurses, but like a dental practice, it’s really just the dentist or the hygienist. And we can take those three reports for a 12-month period and tell them within about five percent what that practice is going to be valued. And so what I would say, if you were going to start just dealing with the PE firm directly, is just send them those three items. And if they can’t come back to you and say, hey, Doc, just off those three items, we think we are going to offer $5 million to $5.3 million for this practice, I would then hit pause again. Because what they’re, I don’t even want to say they’re trying to do this, but they’re also protecting themselves a little bit from talking to a doctor for a long time and then making an offer, then getting all this information and then having to walk that offer back, right? But I wouldn’t go send them everything. I would send them three or four reports for twelve months. And then they might have a couple clarifying questions and things. But if they can’t give you something off that, then that’s a problem.

The way we run our process, if a doctor signs up with us, well, first we would have done that initial valuation that we do not charge for, because part of it is us underwriting the practice and seeing how clean the doctor’s information is, because not all information is created equal. Are their books clean? Is their EMR clean? Is their payroll clean? Because that’s going to drive a lot of other things in the process. And then if the doctor signs up with us, we then have a team that can swarm that practice. We can get access to the QuickBooks, access to the EMR, obviously under NDA and BAA and all that. And we can build a beautiful marketing package in two to four weeks, depending on how clean the doctor’s information is, and if we have to go in and kind of clean up COGS or AR or AP or things that maybe are not being tracked well. So we’re ingesting at least as much information as that initial PE firm asks for. And then we have a booklet, you know, what we call a CIM, a confidential investment memorandum, that we can take to all the potential buyers, and that number depends on type of practice, geography, makeup of the, like even a subset of the type of practice, like a cosmetic dermatology practice is going to have certain buyers, and there’s some overlap as a medical dermatology practice, right? But we can go get IOIs, indications of interest, from multiple parties just off that book.

Stephan Shipe: And then how long does it take after that? So once you start having some indication of interest, you go through the whole process, they’re doing their diligence and structuring the deal. What does it typically look like? So I imagine the range is huge, from someone who says, I’m ready to go, and maybe they’ve gotten all their documents in. You have your two to four weeks to build out a guide. So from the day you start marketing it to PE firms to the time where you have a signed contract?

Thomas Allen: Right. So if, let’s say it’s thirty days, we have our book. If it’s a single doctor practice in one location, two locations, but it’s like one owner, I would hope that there’s a signature on a dotted line and a wire done four or five months after that.

Stephan Shipe: Wow, that’s fast.

Thomas Allen: Yeah, so we can run it pretty quick. But then like, you know, we’re selling a nine location group right now in DFW. And that’s probably going to run more like a nine or ten month process. And a lot of that, you know, where the delay or the change or the variance comes in there, is that quality of earnings, and the LOI process of gathering LOIs, narrowing down, negotiating two, three, four LOIs. It really just depends on how many buyers we have and then how deep is that quality of earnings process that we then enter into after a signed LOI.

Three Years Out: What to Start Doing Now

Stephan Shipe: When you’re talking about quality of earnings, kind of adjacent to that, what are the two or three things that, if I’m three years out from selling a practice and you’re talking to me ahead of time, and I said, what are the two or three things I should do now to make sure that I can get the maximum multiple, or you can get the maximum multiple for me in three years, what are those things?

Thomas Allen: Top three, EMR. Start running your EMR and keeping it super clean. And I know that sounds crazy, it’s easier said than done. You’ve got multiple providers, multiple people helping enter that data, multiple procedures and ways you’re making money, but start getting very regimented with that data lining up with your profit and loss statement, to where the revenue on each of those programs reconciles together. The other thing we see is, if within your practice you’re running on receivables, which a ton of practices are, once again, start making sure those receivables, or if it’s a cash-based practice and there’s maybe prepaid packages that you see maybe in dermatology practices, or discount programs that you might see in like dental practices, make sure you get that organized and tracked. So I guess kind of item one A and two A is really making sure your financial books and your practice books tie well together, to where buyers can see where money is coming from and where it’s flowing. And then the third is really starting to get efficient on your expenses. And I’m not saying you need to go start cutting employee expenses, because employees are what have gotten you there. But start looking at, like, what marketing’s actually working and what’s not. Let’s start trimming down, because I know this is a business owner, we’re busy, especially doctors, they’re busy, they see patients all day, then they’re doing notes. And they’re making plenty of money and it’s easier for them to just kind of forget about some of these expenses. But let’s just remember, every dollar you save is going to be seven to ten dollars for you in exit value. And then if there’s some personal things, right? Like maybe you are paying extra for a great financial advisor and accountant and bookkeeper. Continue doing that, because we can go get you credit for that post-sale. So if you’re paying somebody great, I don’t know, $4,000 a month, and really in a group it’s only going to cost $1,000 a month for your books to get done, we’ll get you credit for that $3,000 a month. But we see a lot of extra spend on marketing and things that we can’t go prove at sale whether or not those expenses are going to continue. So clean information, and go pay attention to your expenses.

Stephan Shipe: Love it. Perfect. Well, Thomas, thank you so much for jumping on here today and going through all that with us. I know it’s a super common topic, and I appreciate you jumping into a lot of different aspects of the deal structure, because it’s something that shows up not only in dental healthcare, but lots of other industries as well. So I appreciate the expertise.

Thomas Allen: Absolutely. Thanks, Stephan. Great talking to you.

Stephan Shipe: That’s our show. Thanks for listening, and we’ll see you next week.

Outro

Disclaimer: The information provided in this podcast is for general informational and educational purposes only, and is not intended to constitute financial, investment, or other professional advice. The opinions expressed are those of the hosts and guests and do not necessarily reflect the views of any affiliated organizations. Investing in financial markets involves risk, including the potential loss of principal. Past performance is not indicative of future results. Before making any investment decisions, you should consult with a qualified financial advisor who can assess your individual financial situation, objectives, and risk tolerance.

What’s Next?

Every relationship begins with a brief intake form so your advisory team can prepare ahead of time and align the conversation to your financial picture and goals. From there, you receive a tailored proposal built around your specific situation, walked through with you in detail so every question is answered before any commitment is made.